RBM17 and hepatocellular carcinoma: Specifically, RBM17 enhances FFA secretion by upregulating HACD3 expression, resulting in a reduction in the population of CD8+ T cells, emphasizing that the importance of RBM17 contribute to the promotion of HCC immunosuppressive microenvironment.